Cytovance Biologics Completes Manufacturing Project for ARMO Biosciences
Cytovance Biologics, a contract manufacturer of mammalian and microbial biologics based in Oklahoma City, announces the successful completion of GMP manufacture of ARMO BioSciences’ lead product, AM0010, a PEGylated form of recombinant human interleukin-10 (PEG-IL-10).
ARMO BioSciences, a clinical-stage biotechnology company based in Redwood City, California, is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases.
Source: Cytovance Biologics